{
  "id": 9504588,
  "title": "Chinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days",
  "url": "https://urgent.news/2026/09/24/chinese-drug-loberamisal-extends-stroke-treatment-window-from-6-hours",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T06:29:27.000Z",
  "source": {
    "name": "South China Morning Post",
    "slug": "south-china-morning-post",
    "url": "https://www.scmp.com/news/china/science/article/3368614/chinese-drug-loberamisal-extends-stroke-treatment-window-6-hours-2-days"
  },
  "original_language": "en",
  "account": null,
  "summary": "Chinese researchers have developed a drug, Loberamisal, that extends the treatment window for stroke from six hours to 48 hours. This breakthrough was demonstrated in a large-scale clinical trial published in the Journal of the American Medical Association on September 10. The study found that 70% of patients who received Loberamisal intravenously within two days of a stroke regained complete functional independence, compared to a 57% recovery rate for those who received standard care. The neuroprotective drug works by reducing brain cell excitability and blocking neuroinflammation and oxidative stress, thereby saving more injured brain cells. If confirmed by subsequent studies, this advancement could significantly improve stroke recovery rates worldwide, where an estimated 12 million new cases occur annually.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Reuters Business via SCMP",
        "title": "Chinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days",
        "url": "https://urgent.news/2026/09/24/chinese-drug-loberamisal-extends-stroke-treatment-window-from-6-hours-9504897",
        "published": "2026-09-24T06:29:27.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}